|
TSG101 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.47019999999321E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
2.0389245847241E-12 |
| Stage1-vs-Stage2 |
3.074600E-01 |
| Stage1-vs-Stage3 |
1.387390E-04 |
| Stage1-vs-Stage4 |
1.927560E-01 |
| Stage2-vs-Stage3 |
2.899100E-03 |
| Stage2-vs-Stage4 |
7.954200E-02 |
| Stage3-vs-Stage4 |
1.616220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.58599799959802E-11 |
| Normal-vs-Asian |
8.192200E-04 |
| Caucasian-vs-AfricanAmerican |
7.065000E-01 |
| Caucasian-vs-Asian |
9.587000E-01 |
| AfricanAmerican-vs-Asian |
9.192800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
2.773600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.34960004177987E-09 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.43740000005488E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.413000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.990800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.069200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.176800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.570800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.405000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.221500E-03 |
| Normal-vs-Grade 2 |
1.22124532708767E-15 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
2.639200E-01 |
| Grade 1-vs-Grade 3 |
3.642400E-02 |
| Grade 1-vs-Grade 4 |
5.501900E-03 |
| Grade 2-vs-Grade 3 |
7.842800E-03 |
| Grade 2-vs-Grade 4 |
6.41789999999975E-05 |
| Grade 3-vs-Grade 4 |
3.095600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
1.94633999999194E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62458935193399E-12 |
| Normal-vs-N1 |
6.86940000438341E-08 |
| N0-vs-N1 |
3.825400E-01 |
|
|
